Viking Therapeutics Inc. (VKTX)’s stock has witnessed a price declined of -1.12% from the previous close with its current price standing at $13.66. Its current price is -46.89% under its 52-week high of $25.72 and 438.96% more than its 52-week low of $2.53. Based on the past 30-day period, the stock price is -16.71% below the high and +3.06% above the low.
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, VKTX’s SMA-200 is $14.32.
VKTX’s price to book ratio for the most recent quarter was 3.50, resulting in an 3.53 price to cash per share for the period.
How does Viking Therapeutics Inc. (VKTX) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 10 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.90 in simple terms.
Viking Therapeutics Inc. (VKTX): Earnings History
If we examine Viking Therapeutics Inc.’s recent earnings history, in the last quarter ended on 6/29/2023, it posted adjusted earnings per share of -$0.19, slashing the consensus of -$0.19. In other words, it beat the consensus by $0, resulting in a 0.00% surprise. In the 3 months period before the previous quarter which was closed on 6/29/2023, the stock recorded adjusted earnings per share of -$0.19 in contrast with the Outlook of -$0.19. That was a difference of $0 and a surprise of 0.00%.
Viking Therapeutics Inc. (VKTX): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 8 different analysts, who are expecting earnings to fall in between the range of -0.18 and -0.24 with an average Earnings Estimate of -0.22 which is in contrast with the last year earnings estimate of -0.21 and also replicates -4.76% growth rate year over year.
An overview of Viking Therapeutics Inc.’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Viking Therapeutics Inc. (VKTX) traded 1,665,450 shares per day, with a moving average of $14.42 and price change of -0.60. With the moving average of $14.52 and a price change of -2.35, about 1,681,510 shares changed hands on average over the past 50 days. Finally, VKTX’s 100-day average volume is 2,494,550 shares, alongside a moving average of $17.82 and a price change of -5.92.
